Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCN-01 in Relapsed or Refractory T-Cell Lymphomas
NCT00082017Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Apr 2004
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 7-hydroxystaurosporine in anaplastic large cell lymphoma (ALCL), mature T-cell lymphoma (PTCL), sponsored by National Cancer Institute. Started Apr 2004; status: terminated.
02
Drugs
7-hydroxystaurosporine
03
Conditions
anaplastic large cell lymphoma (ALCL)mature T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00082017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082017.